However, the previous optimism for Tumor Necrosis Factor-Alpha (TNF-α) targeted therapy, which ultimately failed, suggests that some cytokine-based approaches may have limited roles in the treatment of heart failure (2). The gene discussed is TNF; the disease is heart failure.